Home Haisco's Innovative Drug HSK46256 Tablet Receives NMPA Approval for Clinical Trials in Advanced Solid Tumors

Haisco's Innovative Drug HSK46256 Tablet Receives NMPA Approval for Clinical Trials in Advanced Solid Tumors

Jun 11, 2026 16:54 CST Updated 17:18
Haisco

New Drug Research and Development, Production, and Sales